Veterinary Eye Care

Global Veterinary Eye Care Market to Reach US$5.7 Billion by 2030

The global market for Veterinary Eye Care estimated at US$4.6 Billion in the year 2024, is expected to reach US$5.7 Billion by 2030, growing at a CAGR of 3.5% over the analysis period 2024-2030. Diagnosis, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach US$3.8 Billion by the end of the analysis period. Growth in the Treatment segment is estimated at 4.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.3 Billion While China is Forecast to Grow at 6.5% CAGR

The Veterinary Eye Care market in the U.S. is estimated at US$1.3 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.1 Billion by the year 2030 trailing a CAGR of 6.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.4% and 2.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.0% CAGR.

Global Veterinary Eye Care Market – Key Trends & Drivers Summarized

Why Is Veterinary Eye Care Becoming a Crucial Aspect of Animal Healthcare?

The veterinary eye care market is experiencing significant growth as pet owners and livestock farmers become increasingly aware of the importance of ocular health in animals. Eye diseases such as cataracts, glaucoma, corneal ulcers, and conjunctivitis are prevalent in companion animals, particularly in aging pets and specific breeds predisposed to ocular conditions. With the rising trend of pet humanization, owners are seeking specialized treatments to ensure their pets maintain good vision and overall eye health. In addition to companion animals, eye care for livestock and horses is gaining attention due to the impact of ocular diseases on productivity and performance. Technological advancements in veterinary ophthalmology have also contributed to increased awareness and accessibility to diagnostic tools, surgeries, and pharmaceutical treatments for eye conditions in animals. Moreover, early detection of eye diseases is becoming more common due to improvements in veterinary diagnostics, encouraging pet owners to seek medical intervention before conditions progress to severe or irreversible states. As veterinarians and pet care professionals emphasize preventative eye care, the demand for specialized ophthalmic drugs, surgical procedures, and diagnostic imaging solutions continues to rise, making veterinary eye care an essential segment within the broader veterinary healthcare industry.

What Are the Latest Advancements in Veterinary Eye Care Treatments?

The field of veterinary ophthalmology has seen remarkable technological advancements, leading to more precise diagnostics and effective treatments for various eye diseases in animals. One of the most significant innovations in this field is the use of advanced imaging technologies such as optical coherence tomography (OCT) and ultrasound biomicroscopy, which allow veterinarians to obtain highly detailed images of ocular structures, aiding in early disease detection and treatment planning. The development of minimally invasive surgical techniques, including laser-assisted cataract surgery and corneal grafting, has significantly improved the success rates of vision-restoring procedures in pets. Additionally, researchers are exploring gene therapy for hereditary eye conditions, aiming to correct genetic defects that lead to progressive vision loss in specific dog breeds. The emergence of sustained-release drug delivery systems, such as ocular implants and eye drops with prolonged action, has improved the management of chronic eye conditions like dry eye syndrome and glaucoma. Another promising advancement is the use of regenerative medicine, including stem cell therapy, to restore damaged ocular tissues and treat degenerative eye diseases. As research and development continue to push the boundaries of veterinary ophthalmology, the availability of sophisticated eye care solutions is expected to expand, offering pets and livestock improved ocular health outcomes.

What Challenges Does the Veterinary Eye Care Market Face?

Despite significant advancements, the veterinary eye care market faces several challenges that hinder its widespread adoption and accessibility. One of the primary obstacles is the high cost of advanced ophthalmic treatments, making specialized eye care services financially burdensome for many pet owners. Additionally, there is a shortage of veterinary ophthalmologists, leading to long wait times for specialized consultations and procedures. In many regions, especially in developing countries, access to veterinary eye care is limited due to a lack of diagnostic facilities and trained professionals. Another challenge is the difficulty of diagnosing eye conditions in animals, as symptoms are often subtle, and pets cannot communicate vision problems, leading to delayed treatment. Compliance with treatment regimens also poses a challenge, as administering eye drops or medications to animals can be difficult for pet owners. Moreover, the regulatory landscape for veterinary ophthalmic drugs is complex, requiring extensive research and clinical trials before new treatments reach the market. Addressing these challenges requires increased investment in veterinary ophthalmology training, greater affordability of treatments, and improved awareness campaigns to educate pet owners about the importance of routine eye check-ups for animals.

What Are the Key Growth Drivers of the Veterinary Eye Care Market?

The growth in the veterinary eye care market is driven by several factors, including increasing pet ownership, advancements in veterinary diagnostics, and the rising demand for specialized treatments. One of the key drivers is the aging pet population, as older animals are more prone to developing vision-related disorders, necessitating greater demand for ophthalmic care. The growing popularity of pet insurance is also contributing to market expansion, as more owners can afford specialized treatments for their pets` eye conditions. Additionally, increased funding for veterinary research and the introduction of innovative pharmaceuticals and surgical techniques are accelerating advancements in the field. The expansion of veterinary specialty hospitals and clinics offering dedicated ophthalmology departments has made eye care services more accessible. Another important growth factor is the heightened awareness of zoonotic ocular diseases, prompting stricter regulations and improved preventive measures in livestock and working animals. Moreover, advancements in telemedicine are enabling veterinarians to provide remote consultations for eye conditions, making veterinary ophthalmology services more widely available. As the demand for high-quality veterinary eye care continues to rise, market players are investing in research, product development, and training programs to address the growing needs of animals and their caregivers.

SCOPE OF STUDY:

The report analyzes the Veterinary Eye Care market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Type (Diagnosis, Treatment); Animal Type (Canine, Feline, Equine, Bovine, Other Animal Type); Administration Route (Oral, Topical, Injectable); Indication (Eyelid Abnormalities, Cataract, Glaucoma, Retinal Complications, Uveitis, Conjunctivitis, Corneal Complications, Others); Distribution Channel (Veterinary Hospitals & Clinics, Pet Specialty Stores, E-Commerce, Others)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

• Accutome Inc.
• Alcon Laboratories
• An-Vision GmbH
• Bausch & Lomb Incorporated
• Boehringer Ingelheim
• Ceva Santé Animale
• Dechra Pharmaceuticals
• Dômes Pharma Inc.
• HEINE Optotechnik GmbH
• I-MED Animal Health
• Innovacyn Inc.
• Iridex Corporation
• Jorgensen Laboratories
• LKC Technologies Inc.
• Merck & Co., Inc.
• OptoMed
• Reichert, Inc.
• Virbac
• Vetoquinol
• Zoetis Inc.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.